Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

O60260 (PRKN_HUMAN) Homo sapiens (Human)

E3 ubiquitin-protein ligase parkin UniProtKBInterProSTRINGInteractive Modelling

465 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8); 1 identical sequence: Homo sapiens: X5DR79

Available Structures

14 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
S65DParkin and pUB complex Heteromer
P0CG47;
1-465
PEG;CL;ZN;
Assess
WT-Parkin and pUB complex Heteromer
P0CG47;
1-465
ZN;CL;TMO;
Assess
Structure of phospho-Parkin bound to phospho-ubiquitin Heteromer
P0CG47;
1-378
ZN;GOL;MPD;SO4;
Assess
UbcH7-Ub Complex with R0RBR Parkin and phosphoubiquitin Heteromer
P0CG47; P0CG48; P68036;
144-465
ZN;
Assess
Structure of the autoinhibited Parkin catalytic domainhomo-6-mer142-465
48×ZN; 18×SO4;GOL;
Assess
Parkin (UblR0RBR)monomer1-465
ZN;SO4;GOL;CL;
Assess
Parkin (S65DUblR0RBR)monomer1-465
ZN;GOL;SO4;CL;
Assess
ParkinS65Nmonomer1-465
ZN;SO4;GOL;CL;
Assess
Structure of Parkin-S223P E3 ligasemonomer141-465
ZN;BA;
Assess
Structure of Parkin E3 ligasemonomer141-465
ZN;
Assess
Structure of human Parkin G319Amonomer142-465
ZN;SO4;GOL;
Assess
IBR domain of Human Parkinmonomer308-384
ZN;
Assess
Solution structure of Serine 65 phosphorylated UBL domain from parkinmonomer1-76
Assess
Solution structure of ubiquitin-like domain of human parkinmonomer1-76
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5c1z.1.Amonomer0.741-465
ZN;99.01
Assess
5n2w.1.Amonomer0.691-465
ZN;TMO;91.36
Assess

17 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25c1z.1.Amonomer0.701-437
ZN;98.67
Assess
Isoform 25n2w.1.Amonomer0.651-437
ZN;90.72
Assess
Isoform 36glc.1.Amonomer0.7421-212
ZN;99.53
Assess
Isoform 45c1z.1.Amonomer0.741-274
ZN;100.00
Assess
Isoform 56glc.1.Amonomer0.751-383
ZN;98.90
Assess
Isoform 54k95.1.Amonomer0.681-383
ZN;84.34
Assess
Isoform 55c1z.1.Amonomer0.631-372
ZN;88.40
Assess
Isoform 66glc.1.Amonomer0.811-229
ZN;91.81
Assess
Isoform 65n2w.1.Amonomer0.761-316
ZN;94.94
Assess
Isoform 64k7d.2.Amonomer0.7354-316
ZN;89.35
Assess
Isoform 67r70.2.Amonomer0.591-120
20.00
Assess
Isoform 74k95.1.Amonomer0.621-387
ZN;83.72
Assess
Isoform 76glc.1.Amonomer0.591-377
ZN;85.63
Assess
Isoform 75n2w.1.Amonomer0.571-387
ZN;88.38
Assess
Isoform 84k95.1.Amonomer0.661-415
ZN;82.41
Assess
Isoform 86glc.1.Amonomer0.621-405
ZN;87.53
Assess
Isoform 85n2w.1.Amonomer0.621-415
ZN;TMO;90.42
Assess